---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038462"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:09:37.984108+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $33K convertible note; due March 2025, conversion at $0.0003

## Summary
- Issued convertible promissory note with $33,000 principal ($30,000 net) to GS Capital Partners, LLC.
- Conversion price set at $0.0003 per share, dropping to $0.0001 if stock trades below that for 5 consecutive days.
- Maturity March 25, 2025; 8% annual interest, increasing to 24% on default.
- Proceeds used for general working capital; prepayment options with premiums from 110% to 125% in first 180 days.
- Note issued under Regulation D as unregistered securities exempt under Section 4(a)(2) of Securities Act.

## SEC filing metadata
- accession: 0001493152-24-038462
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315224038462/0001493152-24-038462-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315224038462/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038462
- JSON: https://secwatch.observer/filing/0001493152-24-038462.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038462.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.